A review of radiopharmaceutical development with short-lived generator-produced radionuclides other than 99mTc.
D000336:Aerosols; D001464:Barium; D001761:Bleomycin; D001847:Bone Diseases / Q000175:diagnosis; D001932:Brain Neoplasms / Q000175:diagnosis; D005340:Fibrinogen; D005710:Gallium Radioisotopes; D007204:Indium; D007457:Iodine Radioisotopes; D007495:Iridium; D007553:Isotope Labeling / Q000379:methods; D007674:Kidney Diseases / Q000175:diagnosis; D007726:Krypton; D007962:Leukocytes; D008107:Liver Diseases / Q000175:diagnosis; D008171:Lung Diseases / Q000175:diagnosis; D008863:Microspheres; D009203:Myocardial Infarction / Q000175:diagnosis; D011868:Radioisotopes; D011877:Radionuclide Imaging; D012413:Rubidium; D012709:Serum Albumin; D013326:Strontium Radioisotopes; D014168:Transferrin
D000336:Aerosols; D005710:Gallium Radioisotopes; D007457:Iodine Radioisotopes; D011868:Radioisotopes; D012709:Serum Albumin; D013326:Strontium Radioisotopes; D014168:Transferrin; D007204:Indium; D001761:Bleomycin; D001464:Barium; D007495:Iridium; D007726:Krypton; D005340:Fibrinogen; D012413:Rubidium